Investing.com - vTv Therapeutics Inc (NASDAQ: VTVT) reported first quarter EPS of $-0.060, better than the analyst estimate of $-0.063. Revenue for the quarter came in at $9K versus the consensus estimate of $0.00.
vTv Therapeutics Inc's stock price closed at $0.940. It is up 16.890% in the last 3 months and up 67.830% in the last 12 months.
vTv Therapeutics Inc saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See vTv Therapeutics Inc's stock price’s past reactions to earnings here.
According to InvestingPro, vTv Therapeutics Inc's Financial Health score is "fair performance".
Check out vTv Therapeutics Inc's recent earnings performance, and vTv Therapeutics Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar